A RNase H2‐Linked TaqMan‐MGB Quantitative Real‐Time PCR Assay for Differential Detection of Mycoplasma hyopneumoniae Live‐Attenuated Vaccine Strains

Key Points

• The research aims to develop a TaqMan-MGB assay for accurately detecting live-attenuated vaccine strains of Mycoplasma hyopneumoniae.
• Developed a RNase H2-linked TaqMan-MGB quantitative real-time PCR assay.
• Evaluated assay effectiveness in differentiating between vaccine strains and non-vaccine strains.
• Applied rigorous testing protocols to ensure assay specificity and sensitivity.
• The assay showed a high detection rate of live-attenuated vaccine strains.
• Achieved specificity rates exceeding 95% compared to wild-type strains.
• Demonstrated potential to enhance clinical evaluation of vaccine efficacy.